Insider · CIK 0001233253

HANISH ARNOLD C

Reports to the SEC for 3 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001233253

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	DCOYDecoy Therapeutics Inc.A Award	Director	AAward	+3,000 sh	—	—	3,418
2026-08-27	OMEROMEROS CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	0
2026-08-27	OMEROMEROS CORPS Sale	Director	SSale	−5,000 sh	$18.88	−$94.4K	5,000
2026-08-27	OMEROMEROS CORPS Sale	Director	SSale	−5,000 sh	$19.02	−$95.1K	0
2026-08-27	OMEROMEROS CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	0
2026-08-27	OMEROMEROS CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$15.81	+$39.5K	2,500
2026-08-27	OMEROMEROS CORPM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$14.66	+$110K	10,000
2026-08-26	OMEROMEROS CORPS Sale	Director	SSale	−5,000 sh	$18.53	−$92.6K	0
2026-08-26	OMEROMEROS CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	2,500
2026-08-26	OMEROMEROS CORPM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$15.81	+$79.1K	5,000
2026-06-18	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-12-30	DCOYDecoy Therapeutics Inc.S Sale	Director	SSale	−15 sh	$0.64	−$9.596	5,000
2025-12-30	DCOYDecoy Therapeutics Inc.S Sale	Director	SSale	−12 sh	$0.64	−$7.676	0
2025-11-20	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+5,000 sh	$0.75	+$3,740.5	5,015
2025-06-27	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-06-06	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-02-20	DCOYDecoy Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.5K sh	—	—	20,500
2023-06-23	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-05-22	OMEROMEROS CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2023-05-22	OMEROMEROS CORPS Sale	Director	SSale	−5,000 sh	$6.46	−$32.3K	0
2023-05-22	OMEROMEROS CORPM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.30	+$26.5K	5,000
2023-01-03	DCOYDecoy Therapeutics Inc.A Award	Director	AAward	+1,440 sh	—	—	1,440
2022-09-21	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2022-06-17	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2022-06-03	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+28K sh	$0.18	+$5,152	46,350
2022-01-20	DCOYDecoy Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-09-08	OMEROMEROS CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	5,000
2021-09-08	OMEROMEROS CORPM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$9.44	+$94.4K	10,000
2021-08-10	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+7,000 sh	$0.88	+$6,167	18,350
2021-06-11	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-12-02	DCOYDecoy Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-08-21	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+4,000 sh	$0.98	+$3,920	11,350
2020-08-21	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+4,000 sh	$0.98	+$3,920	11,350
2020-06-05	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-03-23	DCOYDecoy Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2020-02-11	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+4,350 sh	$1.15	+$5,002.5	7,350
2020-02-11	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+4,350 sh	$1.15	+$5,002.5	7,350
2020-02-11	DCOYDecoy Therapeutics Inc. · Warrants (right to buy)P Purchase	Director	PPurchase	+4,350 sh	$0.01	+$43.5	4,350
2019-11-25	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+3,000 sh	$3.59	+$10.8K	3,000
2019-11-25	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+3,000 sh	$3.59	+$10.8K	3,000
2019-11-25	DCOYDecoy Therapeutics Inc.P Purchase	Director	PPurchase	+3,000 sh	$3.59	+$10.8K	6,000
2019-09-10	DCOYDecoy Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,000 sh	—	—	3,000
2019-06-07	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2018-06-15	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2017-06-16	OMEROMEROS CORP · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-06-09	OMEROMEROS CORP · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2015-05-22	OMEROMEROS CORP · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2013-05-24	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2013-01-03	OMEROMEROS CORPP Purchase	Director	PPurchase	+2,000 sh	$5.58	+$11.2K	2,400
2012-09-26	OMEROMEROS CORP · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Sep 24
HANISH ARNOLD C0001233253-26-000006
SEC(opens sec.gov)
Aug 284
HANISH ARNOLD C0001437749-26-029191
SEC(opens sec.gov)
Jun 224
HANISH ARNOLD C0001437749-26-021237
SEC(opens sec.gov)
Jan 24
HANISH ARNOLD C0001615219-26-000004
SEC(opens sec.gov)
Nov 244
HANISH ARNOLD C0001615219-25-000193
SEC(opens sec.gov)
Jul 14
HANISH ARNOLD C0001437749-25-021792
SEC(opens sec.gov)
Jun 74
HANISH ARNOLD C0001437749-24-019707
SEC(opens sec.gov)
Feb 224
HANISH ARNOLD C0001615219-24-000003
SEC(opens sec.gov)
Jun 274
HANISH ARNOLD C0001415889-23-010376
SEC(opens sec.gov)
May 234
HANISH ARNOLD C0001415889-23-008651
SEC(opens sec.gov)

Companies

Address

2450 HOLCOMBE BLVD STE X

HOUSTON, TX, 77021